Zobrazeno 1 - 10
of 72
pro vyhledávání: ''
Autor:
Michela Casanova, Tommaso Giandini, Livellara Virginia, Andrea C. Ferrari, Emilia Pecori, Luca Bergamaschi, Giovanna Sironi, Barbara Diletto, Stefano Chiaravalli, Ombretta Alessandro
Publikováno v:
Tumori Journal. 108:93-97
This study reports the treatment feasibility and efficacy of a novel multiagent intensive treatment program for young patients with desmoplastic small round cell tumor. This small series includes three patients and should be seen as a first suggestio
Publikováno v:
Tumori Journal. 106:NP79-NP83
Background: Papillary renal cell carcinoma (pRCC) represents the second most common histologic subtype of renal cell carcinoma and comprises 2 subtypes. Prognosis for type 2 is associated with poor clinical outcome. Current guidelines are based on ph
Autor:
Giovanni Randon, Marco Maccauro, Melanie Claps, Filippo Pagani, Giulia Apollonio, Giorgia Peverelli, Giuseppe Procopio, Gianluca Aliberti, Alessandra Raimondi, Ettore Seregni, Pierangela Sepe, Elena Verzoni
Publikováno v:
Tumori Journal. 106:406-412
Introduction: Therapeutic decision-making in metastatic castration-resistant prostate cancer (mCRPC) represents an open challenge. Radium-223 is approved for patients with symptomatic bone metastases, no visceral involvement, progressing after at lea
Autor:
Philippe Schafhausen, Carsten Bokemeyer, Judith Dierlamm, Frank Dicker, Snjezana Janjetovic, Anne Marie Asemissen, Mascha Binder
Publikováno v:
Tumori Journal. 105:NP8-NP11
Background: Progression of chronic myeloid leukemia (CML) is frequently accompanied by cytogenetic evolution, with an extra copy of the Philadelphia chromosome, trisomy 8 and 19, and isochromosome (17p) commonly detected. Translocations involving 11q
Autor:
Lisa Argnani, Pier Luigi Zinzani, Claudio Agostinelli, Letizia Gandolfi, Cinzia Pellegrini, Alessandro Broccoli
Publikováno v:
Tumori Journal. 102:S124-S127
Background Autoimmune manifestations may occur in patients with hairy cell leukemia (HCL), and some rare cases of polyarteritis nodosa and leukocytoclastic vasculitis have been reported. However, data regarding the treatment of these cutaneous manife
Autor:
Jordi Remon, Caroline Caramella, Benjamin Besse, Ludovic Lacroix, Christophe Massard, Nathalie Auger, Francesco Facchinetti, Julien Adam, David Planchard, Luc Friboulet, Jean-Charles Soria
Publikováno v:
Tumori Journal. 102:S46-S49
We report on the case of a patient affected by advanced non-small cell lung cancer (NSCLC) harboring an anaplastic lymphoma kinase (ALK) gene rearrangement who did not respond to crizotinib but subsequently benefited from treatment with ceritinib (LD
Autor:
Paul H. Sugarbaker
Publikováno v:
Tumori Journal. 102:588-592
Purpose Adrenal cortical carcinoma is a rare cancer that often presents in an advanced stage. Not only systemic metastases but also local recurrence and peritoneal metastases prevent long-term survival in these patients. Methods A profoundly symptoma
New Drugs in the Treatment of Elderly Patients with Metastatic Castration-Resistance Prostate Cancer
Publikováno v:
Tumori Journal. 102:361-366
Treatment of prostate cancer is continually evolving and new therapies have become available. However, the management of elderly patients is challenging due to their age and comorbidities. Androgen deprivation therapy remains the mainstay treatment o
Autor:
Osman Turkmen, Tolga Tasci, Taner Turan, Derman Basaran, Günsu Kimyon, Alper Karalok, Gökhan Tulunay, Isin Ureyen
Publikováno v:
Tumori Journal. 103:177-181
Objective To define the factors associated with methotrexate (MTX) resistance in patients with low-risk gestational trophoblastic neoplasia (GTN). Methods A total of 63 patients with low-risk GTN according to International Federation of Gynecology an
Autor:
Fabrizio Festinese, Giulia Galli, Giacomo Bregni, Antonia Martinetti, Luigi Mariani, Filippo de Braud, Arpine Gevorgyan, Monica Ganzinelli, Serena Di Cosimo, Elisa Sottotetti, Salvatore Lo Vullo
Publikováno v:
Tumori Journal. 102:e11-e14
Purpose Obesity is a known risk factor for breast cancer and has been linked to increased risk of recurrence and death in breast cancer patients. Little is known about the predictive value of obesity. As endocrine therapy is widely used for breast ca